First Header Logo Second Header Logo

Connection

Steven Feldman to Neoplasms

This is a "connection" page, showing publications Steven Feldman has written about Neoplasms.
Connection Strength

0.322
  1. Persad P, Levender MM, Feldman SR. Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population. Dermatol Online J. 2011 Feb 15; 17(2):10.
    View in: PubMed
    Score: 0.224
  2. Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM, Yamamoto TN, Merchant AS, Mehta GU, Chichura A, Shalem O, Tran E, Eil R, Sukumar M, Guijarro EP, Day CP, Robbins P, Feldman S, Merlino G, Zhang F, Restifo NP. Identification of essential genes for cancer immunotherapy. Nature. 2017 08 31; 548(7669):537-542.
    View in: PubMed
    Score: 0.088
  3. Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, Li S, Dooley LT, Arnold C, Gottlieb AB. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2007 Jan; 56(1):31.e1-15.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.